Covered recipient · General Payments record
KALEY S TUCKER
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$2,655.29
- Reported across 158 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $349.63 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $148.56 | 8 |
| PFIZER INC. | $52.45 | 2 |
| Lilly USA, LLC | $33.65 | 2 |
| Amgen Inc. | $24.75 | 1 |
| Otsuka America Pharmaceutical, Inc. | $23.58 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $21.14 | 1 |
| Novo Nordisk AS | $17.17 | 1 |
| Organon LLC | $14.19 | 1 |
| Acerta Pharma LLC | $14.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.23 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108332854 | CMS |
| ABBVIE INC. | $8.67 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108332856 | CMS |
| ABBVIE INC. | $18.76 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108332858 | CMS |
| ABBVIE INC. | $27.34 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108332860 | CMS |
| ABBVIE INC. | $32.05 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108332862 | CMS |
| ABBVIE INC. | $10.31 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108332864 | CMS |
| ABBVIE INC. | $7.99 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108332866 | CMS |
| ABBVIE INC. | $21.21 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108332868 | CMS |
| Amgen Inc. | $24.75 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117705150 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.14 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105769090 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $21.14 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146762945 | CMS |
| Lilly USA, LLC | $16.46 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135664149 | CMS |
| Lilly USA, LLC | $17.19 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135706314 | CMS |
| Novo Nordisk Inc | $17.17 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100331212 | CMS |
| Organon Llc | $14.19 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136225262 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.58 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119203743 | CMS |
| PFIZER INC. | $24.35 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131123836 | CMS |
| PFIZER INC. | $28.10 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131312320 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.